A notable finding is that audiences are split on whether they see more pharma ads in 2025 compared to 2024. Nearly half of ...
Discover how drugs prevent, cure, and alleviate ailments. Learn about over-the-counter vs. prescription drugs and the ...
Pharma marketers enter 2026 asking where DTC fits in the DTP era. | Pharma marketers enter 2026 asking where DTC fits in the ...
In this episode, HWP CEO Jani Hegarty and SVP of development operations Justin Schlemm share how Health & Wellness Partners is adopting AI internally ...
Stockhead on MSN
Culture testing is becoming pharma’s next battleground, and Clever Culture has a head start
Clever Culture is quietly automating one of pharma’s most unforgiving jobs , turning a regulatory headache into a scalable ...
When patent protection on drugs ends, however, companies face generic competition, as competitors such as Teva make copies of ...
Bristol-Myers Squibb Company is rated a Buy with solid rebound and robust free cash flow margins. Learn more about BMY stock ...
Ascentage Pharma's first approved product, Olverembatinib, is the first novel third-generation BCR-ABL1 inhibitor approved in ...
This Christmas, let’s remember that medications have their place, but they are not the center of our hope. The gifts God gives us — family, faith, fellowship, laughter and the miracle of Christ’s ...
Experts told ABC News that reclassification of the drug would open the doors to more scientific research by removing current ...
Agios upgraded after FDA approval of Aqvesme for thalassemia. Explore AGIO’s financial outlook, upside potential, and future ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback